Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle recall — FDA D-238-2013
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Overview of recall records associated with Dr. Reddy'S Laboratories, including dates, categories and classifications where available.
Classification mix: Class III: 1.
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
This page summarizes recall records in which the official source identifies Dr. Reddy'S Laboratories as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.